Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib

Clinical trial NCT04681820 · UNKNOWN

Trial details

NCT number: NCT04681820
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: UNKNOWN
Study type: OBSERVATIONAL

CML-CP; Mutation;Suboptimal Response or Failure in TKI

Start date: 2020-11-01
Primary completion: 2023-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.